Abstract We investigated the efficacy of photodynamic therapy (PDT) using talaporfin sodium as a new method of synovectomy for rheumatoid arthritis (RA). We first used RA synovial membrane (RASM) for in vitro and in vivo study. The RASM was obtained from patients with RA during total knee replacement. In the in vitro study, RA fibroblast-like synoviocytes (RASCs) obtained from the RASM were examined by fluorescent microscopy to measure the intracellular localization of talaporfin sodium. The cells were then subjected to PDT, and their viability was examined by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium inner salt assay. In the in vivo assay, RASM was obtained as described above, grafted onto severe combined immunodeficiency (SCID) mice and subjected to PDT. The damaged area of RASM was evaluated histologically at 1 day after PDT. Next, we performed a separate experiment using rats with collagen-induced arthritis (CIA). After intra-articular injection of talaporfin sodium, the concentration of talaporfin sodium accumulated in the CIA synovial membrane (CIASM) was compared with that in cartilage, periarticular muscle, and skin. We then performed PDT with intra-articular injection of talaporfin sodium and intra-articular irradiation. The damaged area of the CIASM was measured at 1 day after the PDT, and the articular histological and radiological changes of the ankle were observed at 56 days after the PDT. In RASM, talaporfin sodium accumulated in lysosomes in vitro, and the phototoxicity to RASCs in vitro and to RASM grafted onto SCID mice in vivo depended on the concentration of talaporfin sodium and the laser energy. In CIA rats, there was a greater accumulation of talaporfin sodium in the CIASM than in normal tissue. The CIASM was selectively damaged at 1 day after the PDT, and the bone and cartilage destruction were ameliorated at 56 days after the PDT. In conclusion, PDT using talaporfin sodium might be a new method for synovectomy in patients with RA.
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory disease of the joints characterized by synovial hyperplasia and, in its later stages, cartilage and bone destruction leading to progressive disability [1] . When persistent monoarticular synovitis is resistant to treatment with antiinflammatory drugs, disease-modifying anti-rheumatic drugs, and intra-articular corticosteroids, surgical removal of the inflamed synovium (synovectomy) are generally the principal mode of treatment. Alternative procedures, such as synovectomy or synovium ablation, are restricted to relatively large joints and are not always efficient [2] [3] [4] .
Photodynamic therapy (PDT) is a mode of treatment in which cytotoxic reactions are initiated by exciting photosensitizing substances with light. PDT is used widely in clinical practice for the treatment of cancerous diseases [5] [6] [7] [8] [9] . PDT aims at destroying malignant cells by inducing cytotoxic reactions that result from the interaction between light and photosensitive endo-or exogenous compounds, which are preferentially accumulated in the target tissue.
Several papers have reported the use of PDT in RA animal models [10] [11] [12] [13] [14] [15] . Their results confirmed that PDT can lead to synovial necrosis and may reduce synovial inflammation. In these studies, photosensitizers were injected intravenously and irradiated transdermally or intra-articularly. Unfortunately, most of the photosensitizers currently in use lack selectivity to synovial tissues and provoke skin photosensitivity, which may last for several weeks. Thus, the long-term photosensitivity of the skin is an essential disadvantage [9, 16] and limits the possibility of repetitive treatment. Talaporfin sodium has exhibited excellent photosensitizing properties in in vitro and in vivo studies [9, [17] [18] [19] [20] . Moreover, complete remission was reported in a clinical study on patients with early lung cancer in Japan [21] .
Porfimer sodium and talaporfin sodium are commercially available photosensitizers; in Japan, these substances are used in conjunction with excimer dye laser or diode laser to treat several types of cancer [8, 9] . Because the wavelength (667 nm) absorbed by talaporfin sodium is longer than that absorbed by porfimer sodium (630 nm), the laser light used for talaporfin sodium can penetrate more deeply. Moreover, Kessel et al. [22] reported that because talaporfin sodium has a shorter terminal half-life than porfimer sodium, it is associated with a marked decrease in sun sensitivity. Therefore, PDT with talaporfin sodium may have great potential as a new treatment for RA.
In this study, we performed PDT on the RA synovial membrane (RASM) in vitro and in vivo using local injection of talaporfin sodium. In addition, in rats with collagen-induced arthritis (CIA), talaporfin sodium was injected intra-articularly and then intra-articularly irradiated over a long period of time with a diode laser. This is the first study to investigate the efficacy and side effects of PDT with talaporfin sodium for synovectomy in RA patients and CIA rats.
Materials and methods

Photosensitizer
Talaporfin sodium (C 38 H 37 N 5 Na 4 O 9 ), one of the secondgeneration photosensitizers, was supplied by Meiji Seika Kaisha (Tokyo, Japan). It was dissolved in saline at a concentration of 5 mg/ml for each experiment.
Diode laser
The laser delivery system used was a continuous-wave laser using a wavelength of 664 nm and was supplied by Matsushita Electric Industrial (Tokyo, Japan). In the in vitro experiment, we used a frontal irradiation probe (Fig. 1a) . The power of the diode laser was expressed in units of W/cm 2 , and the energy was expressed in units of J/cm 2 . In the in vivo experiment, we performed PDT on RASM-grafted mice and CIA rats by the interstitial method using a radial irradiation probe with an 8-mm diffusing tip (Fig. 1b) , as described previously [23, 24] . The power of the diode laser was expressed in units of W/cm, and the energy was expressed in units of J/cm.
Cultured RA fibroblast-like synoviocyte
The synovial membrane used in this study was obtained from five patients with RA during the process of total knee replacement. All patients were diagnosed according to the criteria of the American College of Rheumatology used to diagnose RA from 1987 [25] and gave their informed consent; the local ethical committee approved the study protocol. The tissue was digested with 2 mg/ml collagenase (Sigma, St. Louis, MO). The cell pellet obtained after washing was resuspended in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 1% Lglutamine, 100 μg/ml penicillin and 10 μg/ml streptomycin at 37°C in an incubator flushed with 5% CO 2 . Cells were cultured after seeding and processed three to five times, and the RA fibroblast-like synoviocytes (RASCs) thus obtained were used in the experiments. RASCs were seeded onto coverslips and incubated with 25 μg/ml talaporfin sodium for 4 h. The cells were washed twice with phosphate-buffered saline (PBS) and stained with 0.1 μM Nile Blue A, a lysosomal dye, for 2 min at room temperature. They were further washed with PBS, and the fluorescence of talaporfin sodium or Nile Blue A was observed with a fluorescence microscope (XF-EFD; Nikon, Tokyo, Japan) equipped with a V excitation filter or G excitation filter, respectively, which blocks the fluorescence of the other components.
MTT assay
RASCs were seeded in 96-well microplates (Iwaki, Chiba, Japan) at a concentration of 1×10 4 cells per 100 μl/well for 24 h. Then, these cells were incubated with 0-100 μg/ml of taraporfin sodium for 4 h. The cells were washed with PBS and irradiated with 0, 2.5, 5, 10, or 20 J/cm 2 at an output power of 50 mW/cm 2 using a 664-nm diode laser and a frontal irradiation probe. After 24 h, cell viability was measured by a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium inner salt (MTT) assay that measured mitochondrial dehydrogenase activity. The MTT assay was performed using a CellTiter96(R) Aqueous Non-Radioactive Cell Proliferation Assay Kit (Promega, Madison, WI) according to the manufacturer's instructions.
PDT of RASM grafted onto SCID mice Male mice with severe combined immunodeficiency (SCID), 8-10 weeks of age, were purchased from Nippon Charles River (Tokyo, Japan) for use in this study. All of the following experiments were performed according to the rules of animal experimentation and the guidelines for the care and use of laboratory animals of Hamamatsu University School of Medicine.
RASM tissue sample with a diameter of 7-8 mm obtained from RA patients during the process of total knee replacement was implanted subcutaneously in the back of male SCID mice. At 4 weeks after grafting, mice were anesthetized, and PDT was performed. Mice undergoing PDT were divided into two groups. In group I (n=20), the energy of the diode laser was fixed, while in group II (n= 25), the concentration of photosensitizer was fixed. In group I, 0.3 ml talaporfin sodium at a concentration of 0, 0.01, 0.1, or 1.0 mg/ml (n=5 for each subgroup) was injected locally into the RASM grafted onto the back of SCID mice at 4 h before irradiation at 30 J/cm at an output power of 100 mW/cm using a 664-nm diode laser. In group II, 0.3 ml talaporfin sodium at a concentration of 0.1 mg/ml was injected into the mice locally at 4 h before irradiation of 0, 3, 10, 30, or 50 J/cm (n=5 for each subgroup) with the diode laser at an output power of 100 mW/cm using a 664-nm diode laser. The irradiation was performed by the interstitial method as follows. The laser-proof transparent sheath of a 14-G needle was inserted into the RASM, and an optical filter was then inserted with the 8-mm diffusing tip in the center of the RASM for the efficient delivery of light [23, 24] .
Histological analysis of the RASM grafted onto SCID mice after PDT At 24 h after the PDT, the mice were killed, and the grafted RASM was fixed in paraffin. The sagitally orientated histological sections were then taken from the tissue blocks and were divided into two blocks along the longitudinal plane. Sections were stained with hematoxylin and eosin (H&E). The cross-sectional view observed using an optical microscope was captured on a computer for histological evaluation. The damaged areas, necrosis and apoptosis, circled by free hand were calculated using an imageprocessing software program (Image J, National Institutes of Health, USA).
Protocol for induction of collagen-induced arthritis in rats
Male Lewis rats (250-300 g) were used in the study (SLC, Hamamtsu, Japan). All of the following experiments were performed in accordance with the Guidelines for Animal Experimentation of Hamamatsu University School of Medicine. Bovine type II collagen (Sigma) was dissolved in 0.05 M acetic acid and emulsified with an equal volume of Freund's complete adjuvant (Sigma). Rats were immunized intradermally at the base of the tail with 1 ml of emulsion containing 0.5 mg of CII and Freund's complete adjuvant, and at 14 days after the primary immunization, the rats received a booster injection with the same emulsion [8] .
Concentrations of talaporfin sodium in tissue after intra-articular injection Each CIA rat was administered 0.3 ml talaporfin sodium at a concentration of 1.0 mg/ml intra-articularly to the knee. At time points of 0, 1, 4, 8, 24, and 48 h after talaporfin sodium injection, the rats were killed. The tissue accumulation of talaporfin sodium was determined by measuring the fluorescence of tissue homogenates at different times after the administration of talaporfin sodium. Autopsy was performed after each rat death, and the whole knee joints were removed. In each rat, CIA synovial membrane (CIASM), cartilage, muscle, and skin were taken from at least three different sites around the joints. The samples (mean 100 mg) were homogenized thoroughly in distilled water (100 mg wet tissue/4 ml distilled water), and centrifuged at 3,000 rpm for 5 min. The supernatants were excited at 400 nm, and fluorescence emission was scanned at 664 nm by a spectrofluorometer (FP-777; Spectroscopic, Tokyo, Japan). The fluorescence at 664 nm was selected for measurement of talaporfin sodium content in tissue. In the preliminary study, a standard curve was made by the addition of known levels of talaporfin sodium. All measured fluorescent values were revised by the formula derived from the standard curve.
PDT for CIA rats On day 7, after the onset of arthritis, CIA rats were divided into two groups for the performance of PDT. In group I, the energy of the diode laser was fixed, while in group II, the concentration of the photosensitizer was fixed. In group I, we injected 0.3 ml talaporfin sodium at a concentration of 0, 0.01, 0.03, 0.1, 0.3, or 1.0 mg/ml intra-articularly, and at 4 h after injection, just before irradiation at 30 J/cm at an output power of 100 mW/cm using a 664-nm diode laser, we washed the intra-articular space three times with saline.
In group II, we injected 0.3 ml talaporfin sodium at a concentration of 0.3 mg/ml intra-articularly, and at 4 h after injection, just before irradiation at 0, 3, 10, 30, and 50 J/cm at an output power of 100 mW/cm using a 664-nm diode laser, we washed the intra-articular space three times with saline. Laser irradiation was performed intra-articularly using an optical fiber inserted at the knees and ankles under anesthesia. The laser-proof transparent sheath of a 14-G needle was inserted into the joints, and an optical filter was then inserted with the 8-mm diffusing tip in the center of the joints for the efficient delivery of light.
Histological analysis of CIA joints treated with PDT CIASM at 24 h after the PDT At 24 h after the PDT, the rats were killed. The fixed rat knees (n=5 for each subgroup) were decalcified and embedded in paraffin and then divided into two blocks along the longitudinal sagittal plane. Sections were stained with H&E. Representative histological sections of the knees at 24 h after the PDT were taken through the middle of the suprapatellar recess where the optical fiber had been placed during treatment. The synovial recesses of the knees were examined in these sections. The cross-sectional view observed using an optical microscope was captured on a computer for histological evaluation. The damaged areas of CIASM circled by free hand were calculated using an image-processing software program (Image J, National Institutes of Health).
Articular change at 56 days after the PDT At 56 days after the PDT, the rats were killed. The fixed rat ankles (n=12 for each subgroup) were decalcified and embedded in paraffin and then divided into two blocks along the longitudinal sagittal plane. Sections were stained with H&E and safranin O.
The articular changes were observed in representative histological sections of ankles at 56 days after the PDT. The cross-sectional view observed using an optical microscope was captured on a computer for histological evaluation. The surviving cartilage areas circled by free hand were calculated using an image-processing software program (Image J, National Institutes of Health).
X-ray analysis of CIA joints treated with PDT At 56 days after PDT, the ankles of the rats were X-rayed. For each X-ray photograph, articular destruction was graded according to the scales outlined in Fig. 5 .
Statistical analysis
All data are presented as the mean±standard error. The statistical significance of correlation was determined by using Wilcoxon signed-ranks test. Values of p less than 0.05 were considered significant. All analysis was performed on a Macintosh computer using the StatView 5.0 software package.
Results
Intracellular localization of talaporfin sodium
The fluorescence of talaporfin sodium was observed. The results revealed that talaporfin sodium had accumulated in RASCs. We compared the subcellular distribution of talaporfin sodium with that of Nile Blue A, a dye staining lysosomes. When RASCs were double-stained with talaporfin sodium and Nile Blue A, the two fluorescence patterns were in correspondence ( Fig. 2b and c) . The fluorescence pattern of talaporfin sodium was also compared with that of MitoTracker Green FM (Invitrogen Molecular Probes, Carlsbad, CA), a dye staining mitochondria, but the fluorescence patterns were different (data not shown).
MTT assay
After PDT, the cell viability was determined by the MTT assay. For RASC in the study, PDT was effective. The phototoxicity depended on the concentration of talaporfin sodium and the laser irradiation energy. A 50% inhibitory effect was achieved with an irradiation energy of 10 J/cm 2 and concentration of 25 μg/ml talaporfin sodium or by an irradiation energy of 5 J/cm 2 and concentration of 50 μg/ml talaporfin sodium, and an 80% inhibitory effect was acquired by an irradiation energy of 10 J/cm 2 and 50 μg/ml talaporfin sodium (Fig. 2d) .
Histological analysis of SCID mice grafted with RASM after PDT Histologically, the grafted RASM consisted of two main areas (Fig. 3b and c) , one containing mainly fibroblast-like synoviocytes and the other mainly of collagen fiber with a few fibroblast-like synoviocytes. In mice grafted with RASM, fibroblast-like synoviocytes were damaged in both areas ( Fig. 3e and f) . On the cell death pattern, the RASM was damaged after PDT and showed apoptosis and necrosis. In group I, when the drug concentration was higher, the necrosis area/apoptosis area ratio was higher. In group II, when the total energy was higher, the ratio was higher. Moreover, all of the damaged area, apoptosis area and necrosis area, was clearly increased in proportion to the concentration of talaporfin sodium and the laser irradiation energy (Fig. 3g and h ). Table 1 shows the concentrations of all measured values (Y) revised by formula 1 at each time point. The concentration at 0 h is not included because we could not detect the fluorescence at this time point. The concentration of talaporfin sodium in CIASM tended to be higher than that in all normal tissues at all time points, and the ratio of the concentration intensity in CIASM to that in normal tissue was highest at 4 h after injection.
Concentrations of talaporfin sodium in tissue homogenates after intra-articular injection
Histological analysis of CIA joints treated with PDT
At 24 h after PDT
All CIA rat joints without talaporfin sodium or without irradiation showed severe inflammation involving the synovial surface area. Characteristic synovial changes of rheumatoid-like synovitis were seen. Pannus formation was extensive ( Fig. 4a and b) . After PDT, extensive cellular necrosis was seen throughout the full thickness of the synovium ( Fig. 4c and d) . The tissue was damaged in the cylindrical area around the circumstance of the 8-mm probe tip. In the group I, the area damaged by PDT was dependent on the dose of the photosensitizer. At intra-articular injections of up to 0.3 mg/ml of talaporfin sodium, the damaged areas increased in proportion to the concentration of the photosensitizer. However, there was no difference between the 0.3-and 1.0-mg/ml groups (Fig. 4e) . In group II, at irradiation energies of up to 30 J/cm, the damaged areas increased in proportion to the concentration of the photosensitizer, but there was no difference between the 30-and 50-J/cm groups (Fig. 4f) . Figure 5a and g show sections from the ankles of normal rats. There is no inflamed synovial membrane, the cartilage surface is very smooth, and there is no bone destruction. On the other hand, all CIA rat joints showed significant erosion of bone and articular cartilage. Indeed, there was no cartilage layer, and bone was destroyed. In many cases, the pannus had advanced into the bone marrow space (Fig. 5b and h) . In group I, there was an increased reduction in joint destruction compared with the control group. With 0.01 mg/ml of talaporfin sodium, bone destruction was reduced, and the shape of the ankles was maintained, although there were few cartilage layers (Fig. 5c and i) . With up to 0.3 mg/ml of talaporfin sodium, bone and cartilage destruction was greatly reduced because PDT minimized the destruction of cartilage in addition to minimizing the destruction of bone. The reduction in joint destruction with PDT using talaporfin sodium was clearly proportional to the concentration of talaporfin sodium. However, the reduction in cartilage destruction was greater in the 0.3-mg/ml group than in the 1.0-mg/ml group (Fig. 5c-f, i-l, and m) . In group II, the reduction in joint destruction was proportional to the laser irradiation energy used, up to an energy of 30 J/cm. However, no significant difference existed between 30 and 50 J/cm (Fig. 5n) .
At 56 days after PDT
X-ray analysis of CIA joints treated with PDT
The X-ray grades of all CIA rat joints treated with or without PDT are presented in Fig. 6 . All of the joints of CIA rats that did not receive either injection of talaporfin sodium or irradiation showed significant articular destruction. Their X-ray grades were almost all grade IV. In group I, the grade of joint destruction improved. With up to 0.3 mg/ml of talaporfin sodium, the X-ray grades improved in proportion to the concentration of talaporfin sodium. However, the improvement of X-ray grade by PDT with 1.0 mg/ml of talaporfin sodium was less than that by PDT with 0.3 mg/ml of talaporfin sodium. In group II, the improvement of the joint destruction increased in proportion to the laser irradiation energy up to an energy of 30 J/cm, but there was no significant difference between 30 and 50 J/cm (Fig. 6 ).
Discussion
The novel photosensitizer, talaporfin sodium, has been tested in PDT in vitro and in vivo in many tumor models [17] [18] [19] [20] [21] , and it appears to have characteristics of high tumor affinity and rapid elimination from normal tissue. Even so, there have been no reports on the use of PDT with talaporfin sodium to treat RA. We therefore undertook this study on PDT using talaporfin sodium for RA by examining RASM in a xenografted mouse model and CIA rats. It has been suggested that photosensitizers generally accumulated in lysosomes or in mitochondria [26] and that talaporfin sodium accumulates mainly in lysosomes [27] . Our study agreed with these reports, in that talaporfin sodium accumulated mainly in lysosomes of RASC. We suggest that RASCs have a high sensitivity for PDT because uptake of talaporfin sodium in RASCs, determined as an arbitrary unit in each cell by histogram using PhotoShop V software, was significantly higher than that in the synovial membrane of osteoarthritis (data not shown). Moreover, in vitro, PDT using talaporfin sodium was effective on RASCs and was dependent on the dose of the drug and the amount of laser energy. In vivo, the damaged area of RASM was clearly dependent on the dose of talaporfin sodium and the amount of laser energy in the xenografted mouse model. RA is a chronic inflammatory disease, which is characterized by synovial hyperplasia, inflammation, and joint destruction [1] . The excessive growth of RASM is thought to be responsible for the formation of pannus that invades adjacent tissue, including cartilage and bone. Moreover, it is thought that factors such as cytokines, chemokines, and various matrix metalloproteinases emitted by RASM complicate the disease [28] [29] [30] [31] [32] [33] . Therefore, RASM is regarded as an essential therapeutic target. The effectiveness of PDT on RASCs and RASM in the present study suggests that PDT with talaporfin sodium might be developed as a new clinical treatment for RA.
Talaporfin sodium accumulated mainly in lysosomes. In many instances, lysosomal permeabilization appears to be an early event in the apoptotic cascade, preceding other hallmarks of apoptosis like destabilization of mitochondria and caspase activation. Massive lysosomal breakdown results in cellular necrosis, whereas a partial and selective lysosomal permeabilization is associated with the induction of apoptosis [26, [34] [35] . In our study, when the drug concentration or irradiation energy was higher, the necrosis area/apoptosis area ratio was higher. The reason may be that massive lysosomal breakdown by PDT occurred with high irradiation energy or high drug concentration, while selective lysosomal permeabilization occurred by PDT in low irradiation energy or low drug concentration.
We have indicated that the fluorescence intensity of intra-articularly injected talaporfin sodium was higher in CIASM than in the other tissues within 48 h after the injection. Only a very small amount of talaporfin sodium was found in the tissue samples, including periarticular skin, muscle, and cartilage. Thus talaporfin sodium appears to have a high affinity for the synovium in joints. We surmised that the levels of talaporfin sodium were so low in periarticular skin and muscle after intra-articular injection because the joint capsule is an ideally compartmentalized system. Thus, intra-articular drug administration offers numerous advantages. In our previous study, when we performed PDT by intravenous injection of 1.0 mg/kg talaporfin sodium and intra-articular irradiation for CIA rats, there were signs of skin and muscle necrosis around the joints.
As shown in Table 1 , the mean ratio of the concentration of talaporfin sodium in CIASM to that in the other tissues was greatest at 4 h after administration of talaporfin sodium. This may suggest that PDD and PDT for CIASM should be performed at 4 h after talaporfin sodium administration. The significance of this observation was that periarticular tissues should be relatively unaffected by light because only small amounts of photosensitizer accumulate in these areas. In the histological analysis of the joints of CIA rats treated with PDT, in group I administered up to 0.3 mg/ml of talaporfin sodium, the damaged areas increased in proportion to the concentration of the photosensitizer at 24 h after PDT, and bone and cartilage destruction improved more in proportion to the concentration of the photosensitizer at 56 days after PDT. The results of X-ray analysis of joint destruction were similar to the results of the histological analysis. However, the improvement in the reduction in bone and cartilage destruction with PDT with 1.0 mg/ml talaporfin sodium decreased compared with 0.3 mg/ml talaporfin sodium. We suggest the reason is that cartilage tissues were affected by PDT because the concentrations of photosensitizer in cartilage tissue were high. When we administered PDT with 0.1-10 mg/ml talaporfin sodium to normal rats, we confirmed that there were slight irregularities on the surface of cartilage at the concentration of 1.0 mg/ml. Therefore, the aggravation of joint destruction by the damage to cartilage was greater than the reversal of joint destruction accomplished by synovectomy in the case of PDT with 1.0 mg/ml talaporfin sodium. In group II, using up to 30 J/cm of irradiation energy, the damaged areas increased in proportion to the energy of irradiation at 24 h after PDT, and bone and cartilage destruction were reduced in proportion to the energy of irradiation at 56 days after PDT. However, there was no difference in the damaged areas of CIASM at 24 h after PDT, and no improvement in the reduction in bone and cartilage destruction between 30 and 50 J/cm PDT. We therefore consider that irradiation at 30 J/cm is adequate.
In addition to talaporfin sodium, porfimer sodium is a commercially available photosensitizer that has been applied to the treatment of several types of cancer. A major disadvantage of first-generation photosensitizers such as porfimer sodium is the potential for drug-induced sensitivity to sunlight. This is not trivial and may result in symptoms ranging from slight erythema and edema to extensive skin damage and necrosis. Ideally, the photosensitizer should be modified to avoid the deleterious effects on normal skin tissue upon light exposure. Nelson et al. [36] reported that animals that received PDT using talaporfin sodium showed no deleterious side effects, whereas animals receiving PDT using porfimer sodium suffered adverse skin reactions. Tsukagoshi et al. [37] reported that the photosensitivity of talaporfin sodium mostly disappeared within 2 weeks in a clinical setting. The lack of skin-related side effects clearly constitutes an advantage for the use of talaporfin sodium PDT. In our study, it was not necessary to shade rats from light, as PDT by intra-articular administration of talaporfin sodium uses less quantity of talaporfin sodium than that by intravenous administration and talaporfin sodium has a shorter half-life than the currently used photosensitizer.
Conclusions
We have demonstrated that PDT with talaporfin sodium was effective for the synovial membrane of patients with RA both in vitro and in vivo as well as on the synovial membrane of rats with CIA. The effectiveness depended on the concentration of talaporfin sodium and the laser irradiation energy. If talaporfin sodium was to be introduced in appropriate concentrations combined with optimal irradiation energy, PDT with talaporfin sodium could become a new clinical treatment for synovectomy in RA patients.
